Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How HLA-B27 Research Landmarks, Advances Relate to Ankylosing Spondylitis Pathogenesis

Joerg Ermann, MD  |  Issue: July 2016  |  July 13, 2016

MHC class I molecules are expressed on all body cells, where they “present” bound peptides to CD8+ T cells to facilitate peptide-specific cytotoxic T cell responses. MHC class I molecules also interact with a variety of natural killer (NK) cell receptors. This interaction is not peptide specific, although it has been demonstrated that peptide sequences may affect binding strength of some NK cell receptors. MHC class I molecules play critical roles in immune responses against tumors and viruses.

The pathway leading to formation of the HC/b2m/peptide complex (see Figure 1, above) was mapped out in the 1990s:10 Cytosolic proteins (including viral proteins in infected cells or tumor-associated proteins in cancer cells) are degraded by the proteasome. Peptides are then transported from the cytosol into the endoplasmic reticulum (ER) by a peptide pump called TAP (transporter associated with antigen processing). In the ER, these peptides are loaded into the peptide binding groove of nascent MHC class I molecules. This involves the interaction with chaperone proteins that facilitate the correct folding of the HC/b2m/peptide complex. Further, peptidases like ERAP1 (ER amino­peptidase 1) trim the peptides to a length of 8–9 amino acids, which is the optimal size to fit into MHC class I molecules. Once correctly assembled, the HC/b2m/peptide complex moves through the Golgi apparatus to the cell surface.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The amino acid sequence of the MHC class I HC determines which peptides can be loaded and presented on the cell surface (i.e., different MHC alleles present different peptides). The high degree of heterogeneity of HC sequences is thought to represent a safety mechanism that prevents pathogens from escaping an adaptive immune response by mutating their protein sequences so that no pathogen-derived peptide can be presented by any MHC molecule.

MHC Nomenclature & HLA-B27 Variants

The sequences of the polymorphic HLA genes are curated by the WHO Nomenclature Committee for Factors of the HLA System. The current system uses an eight-letter code to cate­gorize each newly discovered MHC class I allele.11 In HLA-B*27:05:02:01, the B refers to the gene locus; the first two digits after the * identify an allele family, which in general corresponds to serological reactivity (e.g., HLA-B27 vs. HLA-B08); sub­sequent numbers separated by colons group alleles in a hierarchical manner according to differences in amino acid sequence, nucleo­tide sequence of the coding region and nucleotide sequence of introns/untranslated regions. For example, the protein sequence of HLA-B*27:04 differs from HLA-B*27:05 by three amino acid residues, whereas in HLA-B*27:05:02 and HLA-B*27:05:03 the same amino acid sequence is encoded by a slightly different nucleotide sequence owing to the redundancy of the genetic code.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 8 9 | Single Page
Share: 

Filed under:Axial SpondyloarthritisConditionsOther Rheumatic Conditions Tagged with:Ankylosing SpondylitisHLA-B27

Related Articles

    Conformational Flexibility in HLA-B27 Provides Clues to Development of Ankylosing Spondylitis

    July 11, 2016

    Understanding how human leukocyte antigen (HLA) class I molecule B27 promotes spondyloarthritis has intrigued researchers for four decades. Although the association between the single gene variant HLA-B27—specifically some of its subtypes—with ankylosing spondylitis (AS) is particularly strong, how HLA-B27 directly influences disease development has not yet been clearly explained, although hypotheses continue to be generated….

    Data Accumulate to Suggest HLA-B27 Status May Drive Axial Phenotype in SpA

    May 20, 2022

    HLA-B27 may be a phenotypic expression of axial spondyloarthritis (SpA), according to a large international study. The study found patients with axial SpA who were positive for HLA-B27 had more severe radiographic damage than those who were negative for HLA-B27, and three quarters of study patients with ankylosis spondyloarthritis were HLA-B27 positive.

    Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

    May 1, 2014

    New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

    Biophoto Associates / Science Source

    A Stiff Man: A Case Study in Ankylosing Spondylitis

    July 12, 2017

    First Appearances I watched the old man, his back painfully bent, shuffle toward the scale. A blocky rigidity draped over him. His feet seemed stuck to the floor. His head hung heavily over his chest. Observing him from the end of the hallway, instead of a face, I saw only a mound of shaggy, matted…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences